Author:
Kim Go Woon,Chung Sung Hyun
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference53 articles.
1. Asano, T., T. Ogihara, H. Katagiri, H. Sakoda, H. Ono, M. Fujishiro, M. Anai, H. Kurihara, and Y. Uchijima. 2004. Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs. Current Medicinal Chemistry 11: 2717–2724.
2. Bailey, C.J., J.L. Gross, A. Pieters, A. Bastien, and J.F. List. 2010. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycemic control with metformin: A randomized, double-blind, placebo-controlled trial. Lancet 375: 2223–2233.
3. Black, C., P. Donnelly, L. Mcintyre, P.L. Royle, J.P. Shepherd, and S. Thomas. 2007. Meglitinide analogues for type 2 diabetes mellitus. The Cochrane Database of Systematic Reviews 2: CD4654.
4. Bode, B., K. Stenlöf, D. Sullivan, A. Fung, and K. Usiskin. 1995. Efficacy and safety of canagliflozin treatment in older subjects with type 2 diabetes mellitus: A randomized trial. Hospital Practice 41: 72–84.
5. Bolinder, J., O. Ljunggren, J. Kullberg, L. Johansson, J. Wildding, A.M. Langkilde, J. Sugg, and S. Parikh. 2012. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. The Journal of Clinical Endoclinology & Metabolism 97: 1020–1031.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献